All I am saying is GMP does not equal a license to distribute Cannepil. I accept that its a step required to move to the next stage and that a similar product produced by another company is already approved for sale. That still does not mean that Cannepil has approval yet.
My other point was to do with misleading announcements from the BOD some months ago which read like it was already being distributed.
Revenue will always be the key as I have said many times. Let’s hope that the BOD doesn’t stuff things up from here. Based on previous Ann’s the market will not re rate this company until it sees hard evidence of revenues.
- Forums
- ASX - By Stock
- RGT
- Ann: Trading Halt
Ann: Trading Halt, page-71
-
- There are more pages in this discussion • 69 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
IGO
IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity
NVA
Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter
Add RGT (ASX) to my watchlist
|
|||||
Last
28.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.79M |
Open | High | Low | Value | Volume |
28.5¢ | 28.5¢ | 28.0¢ | $15.14K | 53.18K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 73 | 28.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.5¢ | 3187 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 73 | 0.285 |
2 | 11127 | 0.280 |
1 | 7100 | 0.275 |
2 | 13700 | 0.270 |
1 | 2000 | 0.260 |
Price($) | Vol. | No. |
---|---|---|
0.295 | 3187 | 1 |
0.300 | 1000 | 1 |
0.310 | 5530 | 2 |
0.370 | 1056 | 1 |
0.380 | 1047 | 1 |
Last trade - 13.52pm 29/07/2024 (20 minute delay) ? |
Featured News
RGT (ASX) Chart |